Model‐based exposure‐response analysis to quantify age related differences in the response to scopolamine in healthy subjects

Eitemau Tebyg

• An anti‐nicotinic cognitive challenge model using mecamylamine in comparison with the anti‐muscarinic cognitive challenge using scopolamine
  gan: Baakman, Anne Catrien, et al.
  Cyhoeddwyd: (2017)
• Pharmacokinetic–pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects
  gan: Liem-Moolenaar, Marieke, et al.
  Cyhoeddwyd: (2011)
• No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge model
  gan: Baakman, Anne Catrien, et al.
  Cyhoeddwyd: (2019)
• No synergistic effect of subtherapeutic doses of donepezil and EVP‐6124 in healthy elderly subjects in a scopolamine challenge model
  gan: Anne Catrien Baakman, et al.
  Cyhoeddwyd: (2019-01-01)
• Reversal of mecamylamine‐induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responses
  gan: Alvarez‐Jimenez, Ricardo, et al.
  Cyhoeddwyd: (2018)